Syrian mesquite

Prosopis farcta · Accepted scientific name

Scientific literature: Very Sparse (42 studies) · ★☆☆☆☆

Syrian mesquite, scientifically known as Prosopis farcta, is a resilient, thorny shrub native to the arid regions of the Middle East and Mediterranean. Valued in traditional medicine, it possesses diverse therapeutic properties, including antimicrobial and anti-inflammatory effects, making it a significant botanical resource for treating various ailments.

Family
Fabaceae
Native range
Africa
Parts used
Leaf · Root
Common names
Syrian Mesquite
Scientific synonyms
Prosopis Farcta Var. Glabra · Acacia Persica · 10 more

Names and Synonyms

Common Names

Scientific Names

Accepted name

Prosopis farcta

Synonyms

Regional and Traditional Names

Spanish:

  • Mezquite sirio

Sources: Wikidata, Catalogue of Life

Taxonomical Classification

This plant belongs to the kingdom Plantae within the phylum Streptophyta and the class Equisetopsida. It is further classified under the subclass Magnoliidae in the order Fabales, falling into the family Fabaceae. Ultimately, it is identified by the genus Prosopis.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Fabales
Family Fabaceae
Genus Prosopis

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

This plant is widely distributed across several distinct regions in both Africa and Asia. In Northern Africa, its presence is well-documented within the countries of Algeria and Egypt. It can also be found growing across the landscapes of Libya and Tunisia. Moving beyond the African continent, the species extends its range into Central Asia. Specifically, it inhabits the vast territories of Kazakhstan.

Region Area
Northern Africa Algeria
Northern Africa Egypt
Northern Africa Libya
Northern Africa Tunisia
Central Asia Kazakhstan
Central Asia Kirgizstan
Central Asia Turkmenistan
Central Asia Tadzhikistan
Central Asia Uzbekistan
Caucasus Transcaucasus

Sources: The World Checklist of Vascular Plants (WCVP)

Botanical Identification

Ecology

The ecology of Prosopis farcta is characterized by its remarkable adaptability to diverse and often extreme environmental conditions. It thrives across a wide variety of habitats, including desert landscapes, hilly terrains, riparian zones near rivers, saline environments, and coastal areas such as seas and shores. This plant demonstrates significant altitudinal plasticity, occupying an elevational range that extends from a minimum of 400 m AMSL to a maximum of 1200 m AMSL.

Elevational range max:
1200 m AMSL
Elevational range min:
400 m AMSL
Habitat :
desert, hills, rivers, saline places, sea, shores

Life history

The life history of Prosopis farcta is characterized by a perennial lifecycle, allowing the plant to persist through multiple growing seasons within its environment. Regarding its structural classification and growth habit, it is identified as a phanerophyte, specifically categorized under the life forms of phanerophyte and nanophanerophyte, indicating that its regenerative buds are located on aerial shoots well above the soil surface.

Life form :
phanerophyte
Lifecycle :
perennial

Morphology

The morphology of Prosopis farcta is characterized by its growth form as a self-supporting shrub, exhibiting a woody structure that provides stability. It is a terrestrial plant, typically found in non-aquatic environments, and functions as an independent organism without parasitic tendencies. In terms of stature, it maintains a relatively low profile, with a maximum plant height reaching approximately 0.5 meters.

Aquatic :
terrestrial
Climber :
self-supporting
Growth form :
shrub
Parasite :
independent
Plant height max:
0.5 m
Woodiness :
woody

Physiology

The physiology of Prosopis farcta is characterized by a highly specialized metabolic framework designed to facilitate survival in arid and semi-arid environments. Central to its carbon assimilation process is its photosynthetic pathway, which functions exclusively via the C3 mechanism. This pathway involves the direct fixation of atmospheric carbon dioxide by the enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) within the mesophyll cells to form 3-phosphoglycerate. To mitigate the physiological stresses associated with C3 photosynthesis in high-temperature or water-limited habitats, such as photorespiration and transpiration-driven water loss, the plant employs robust adaptive strategies. These include efficient stomatal regulation to balance gas exchange with water conservation and an extensive root system architecture that optimizes hydraulic conductance and nutrient uptake from deep soil profiles, thereby supporting the metabolic demands of its C3 photosynthetic processes.

Photosynthetic pathway :
C3

Reproduction

The reproduction of Prosopis farcta is characterized by a specific seasonal flowering period that typically begins in May and concludes in June. The plant produces fruit in the form of a pod, which is a dehiscence type, meaning it splits open at maturity to release its seeds. The seeds produced by this species exhibit significant variation in weight; the average seed mass is approximately 0.228223333 g, with individual seeds ranging from a minimum of 0.05521 g to a maximum of 0.5528 g.

Dehiscence :
dehiscent
Flowering time :
May
Flowering time :
Jun
Fruit type :
pod
Seed mass max:
0.5528 g
Seed mass mean:
0.228223333 g
Seed mass min:
0.05521 g

Sources: Global Inventory of Floras and Traits (GIFT)

Plant Parts

Prosopis farcta has 2 reported plant parts identified across 2 scientific publications and several other databases that are studied for medicinal purposes. The most consistently reported plant part include leaf, root.

Plant parts reported in Prosopis farcta
Plant part Supporting sources Consensus
Leaf 1 supporting sources ★☆☆☆☆
Root 1 supporting sources ★☆☆☆☆

Leaf

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Root

  1. Pharmacognosy magazine

Chemicals

Prosopis farcta has 15 reported phytochemicals identified across 2 scientific publications and several other databases. The most consistently reported chemicals include luteolin, CATECHIN, CD, CHLOROGENIC ACID, CU.

Chemicals reported in Prosopis farcta
Chemical Supporting sources Consensus
luteolin 3 supporting sources ★★☆☆☆
CATECHIN 1 supporting sources ★☆☆☆☆
CD 1 supporting sources ★☆☆☆☆
CHLOROGENIC ACID 1 supporting sources ★☆☆☆☆
CU 1 supporting sources ★☆☆☆☆
FAT 1 supporting sources ★☆☆☆☆
Fatty acids 1 supporting sources ★☆☆☆☆
Flavonoid 1 supporting sources ★☆☆☆☆
Flavonoids 1 supporting sources ★☆☆☆☆
Glycosides 1 supporting sources ★☆☆☆☆

luteolin

  1. Cell biochemistry and function
  2. Evidence-based complementary and alternative medicine : eCAM
  3. Medical science monitor basic research

CATECHIN

  1. Cellular and molecular biology (Noisy-le-Grand, France)

CD

  1. International journal of phytoremediation

CHLOROGENIC ACID

  1. Cellular and molecular biology (Noisy-le-Grand, France)

CU

  1. International journal of phytoremediation

FAT

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Fatty acids

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Flavonoid

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Flavonoids

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Glycosides

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Activities

Prosopis farcta has 4 reported activities identified across 2 scientific publications and several other databases. The most consistently reported activities include Antibacterial, Antidiabetic, Apoptotic, Cytotoxic.

Activities reported in Prosopis farcta
Activity Supporting sources Consensus
Antibacterial 1 supporting sources ★☆☆☆☆
Antidiabetic 1 supporting sources ★☆☆☆☆
Apoptotic 1 supporting sources ★☆☆☆☆
Cytotoxic 1 supporting sources ★☆☆☆☆

Antibacterial

  1. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Antidiabetic

  1. Pharmacognosy magazine

Apoptotic

  1. Molecular biology reports

Cytotoxic

  1. Molecular biology reports

Conditions

Prosopis farcta has 12 reported investigations on conditions identified across 2 scientific publications and several other databases. The most consistently reported conditions include hyperglycemia, Cardiovascular diseases, Diabetes mellitus, asthma, cancers.

Conditions investigated for Prosopis farcta
Condition Supporting sources Consensus
Hyperglycemia 2 supporting sources ★☆☆☆☆
Cardiovascular diseases 1 supporting sources ★☆☆☆☆
Diabetes mellitus 1 supporting sources ★☆☆☆☆
Asthma 1 supporting sources ★☆☆☆☆
Cancers 1 supporting sources ★☆☆☆☆
Cell death 1 supporting sources ★☆☆☆☆
Conjunctivitis 1 supporting sources ★☆☆☆☆
Diabetes mellitus 1 supporting sources ★☆☆☆☆
Diarrhea 1 supporting sources ★☆☆☆☆
Ischemia 1 supporting sources ★☆☆☆☆

Hyperglycemia

  1. Pharmacognosy magazine
  2. Advanced biomedical research

Cardiovascular diseases

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Diabetes mellitus

  1. Pharmacognosy magazine

Asthma

  1. Biomolecules

Cancers

  1. Molecular biology reports

Cell death

  1. Evidence-based complementary and alternative medicine : eCAM

Conjunctivitis

  1. Biomolecules

Diabetes mellitus

  1. Advanced biomedical research

Diarrhea

  1. Biomolecules

Ischemia

  1. Evidence-based complementary and alternative medicine : eCAM

Preparations

Prosopis farcta has 11 reported preparations identified across 2 scientific publications and several other databases. The most consistently reported preparations include PFE, aqueous extract, P. farcta bean extract, PFEs, Prosopis farcta extract.

Preparations reported for Prosopis farcta
Preparation Supporting sources Consensus
Pfe 2 supporting sources ★☆☆☆☆
Aqueous extract 2 supporting sources ★☆☆☆☆
P. farcta bean extract 1 supporting sources ★☆☆☆☆
Pfes 1 supporting sources ★☆☆☆☆
Prosopis farcta extract 1 supporting sources ★☆☆☆☆
Ethanolic extract 1 supporting sources ★☆☆☆☆
Ethyl acetate extract 1 supporting sources ★☆☆☆☆
Extract of prosopis farcta 1 supporting sources ★☆☆☆☆
Extracts 1 supporting sources ★☆☆☆☆
Infusion (inf) extract 1 supporting sources ★☆☆☆☆

Pfe

  1. Evidence-based complementary and alternative medicine : eCAM
  2. Medical science monitor basic research

Aqueous extract

  1. Molecular biology reports
  2. Cellular and molecular biology (Noisy-le-Grand, France)

P. farcta bean extract

  1. Advanced biomedical research

Pfes

  1. Advanced biomedical research

Prosopis farcta extract

  1. Cell biochemistry and function

Ethanolic extract

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Ethyl acetate extract

  1. Cellular and molecular biology (Noisy-le-Grand, France)

Extract of prosopis farcta

  1. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Extracts

  1. Advances in colloid and interface science

Infusion (inf) extract

  1. Pharmacognosy magazine